Sapio Sciences and Ultima Genomics form multi-omics research partnership
Ella Day | September 11, 2025 | News story | Medical Communications, Research and Development | Sapio Sciences, Ultima Genomics, biotech, genomics research
Sapio Sciences and Ultima Genomics have formed a strategic partnership to accelerate genomics research. The collaboration aims to make multi-omics workflows more accessible and streamlined for researchers.
Sapio Sciences’ informatics platform streamlines complex workflows, unifies scientific data and enables faster, smarter decisions across biopharma research and development, clinical diagnostics and manufacturing.
Ultima Genomics’ multi-omics sequencing capabilities allow researchers to study layers of biology beyond DNA sequences alone.
Gilad Almogy, CEO and founder of Ultima Genomics, said: “Partnering with Sapio Sciences aligns with our goals to enable leading sequencing labs and make genomic information more scalable. By integrating our high-throughput, low-cost sequencing platform with Sapio’s AI-powered lab informatics platform, we’re enabling a seamless, scalable solution for multi-omics research and clinical genomics.
Almogy continued: “We’re excited to empower organizations to accelerate discovery, drive AI-powered insights, and bring high-quality genomics into everyday workflows with unmatched efficiency and traceability.”
Andrew Wyatt, chief growth officer at Sapio Sciences added: “This partnership gives Ultima’s customers a direct path to combining world-class sequencing with equally powerful informatics. By removing workflow complexity, we’re making it easier for labs to manage multi-omics data, gain insights faster and scale without compromising quality or compliance.”
Related Content
Cellbyte raises $2.75m to fund pharma drug launch platform
Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of …
Lilly opens fourth US Gateway Labs site
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …
